These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 11028577)

  • 21. Methyldopa versus no drug treatment in the management of mild pre-eclampsia.
    Elhassan EM; Mirghani OA; Habour AB; Adam I
    East Afr Med J; 2002 Apr; 79(4):172-5. PubMed ID: 12625668
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Urinary protein excretion and expectant management of early onset, severe pre-eclampsia.
    Hall DR; Odendaal HJ; Steyn DW; Grové D
    Int J Gynaecol Obstet; 2002 Apr; 77(1):1-6. PubMed ID: 11929649
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Conservative management of eclampsia and severe pre-eclampsia--A Bangladesh experience.
    Begum MR; Akhter S; Begum A; Khatun M; Quadir E; Choudhury SB
    Medscape Womens Health; 2002 Jan; 7(1):1. PubMed ID: 11965219
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Management of eclampsia at Assiut University Hospital, Egypt.
    Abd El Aal DE; Shahin AY
    Int J Gynaecol Obstet; 2012 Mar; 116(3):232-6. PubMed ID: 22189064
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immediate delivery versus expectant monitoring for hypertensive disorders of pregnancy between 34 and 37 weeks of gestation (HYPITAT-II): an open-label, randomised controlled trial.
    Broekhuijsen K; van Baaren GJ; van Pampus MG; Ganzevoort W; Sikkema JM; Woiski MD; Oudijk MA; Bloemenkamp KW; Scheepers HC; Bremer HA; Rijnders RJ; van Loon AJ; Perquin DA; Sporken JM; Papatsonis DN; van Huizen ME; Vredevoogd CB; Brons JT; Kaplan M; van Kaam AH; Groen H; Porath MM; van den Berg PP; Mol BW; Franssen MT; Langenveld J;
    Lancet; 2015 Jun; 385(9986):2492-501. PubMed ID: 25817374
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Severe pre-eclampsia and hypertensive crises.
    Arulkumaran N; Lightstone L
    Best Pract Res Clin Obstet Gynaecol; 2013 Dec; 27(6):877-84. PubMed ID: 23962474
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expectant management of severe preeclampsia remote from term: patient selection, treatment, and delivery indications.
    Sibai BM; Barton JR
    Am J Obstet Gynecol; 2007 Jun; 196(6):514.e1-9. PubMed ID: 17547875
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Management of severe, early pre-eclampsia: is conservative management justified?
    Oláh KS; Redman CW; Gee H
    Eur J Obstet Gynecol Reprod Biol; 1993 Oct; 51(3):175-80. PubMed ID: 8288012
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Maternal and perinatal outcome of preeclampsia with an onset before 24 weeks' gestation. Audit in a tertiary referral center.
    Gaugler-Senden IP; Huijssoon AG; Visser W; Steegers EA; de Groot CJ
    Eur J Obstet Gynecol Reprod Biol; 2006; 128(1-2):216-21. PubMed ID: 16359774
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Magnesium sulphate: a life saving drug.
    Thapa K; Jha R
    JNMA J Nepal Med Assoc; 2008; 47(171):104-8. PubMed ID: 19079372
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The impact of fetal growth restriction on latency in the setting of expectant management of preeclampsia.
    McKinney D; Boyd H; Langager A; Oswald M; Pfister A; Warshak CR
    Am J Obstet Gynecol; 2016 Mar; 214(3):395.e1-7. PubMed ID: 26767794
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pregnancy outcome in eclamptics at the University of Abuja Teaching Hospital, Gwagwalada, Abuja: a 3 year review.
    Agida ET; Adeka BI; Jibril KA
    Niger J Clin Pract; 2010 Dec; 13(4):394-8. PubMed ID: 21220852
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Severe pre-eclampsia and eclampsia.
    Walker JJ
    Baillieres Best Pract Res Clin Obstet Gynaecol; 2000 Feb; 14(1):57-71. PubMed ID: 10789260
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An audit of the use of magnesium sulphate in severe pre-eclampsia and eclampsia.
    Singh J; O'Donovan M; Coulter-Smith SD; Geary M
    J Obstet Gynaecol; 2005 Jan; 25(1):15-7. PubMed ID: 16147685
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Is expectant management of early-onset severe preeclampsia worthwhile in low-resource settings?
    Abdel-Hady el-S; Fawzy M; El-Negeri M; Nezar M; Ragab A; Helal AS
    Arch Gynecol Obstet; 2010 Jul; 282(1):23-7. PubMed ID: 19693521
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 24-hour blood pressure monitoring to evaluate the effects of nifedipine in pre-eclampsia and in chronic hypertension in pregnancy.
    Benedetto C; Zonca M; Giarola M; Maulà V; Chiarolini L; Carandente F
    Br J Obstet Gynaecol; 1997 Jun; 104(6):682-8. PubMed ID: 9197871
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A comparison between the haemodynamic effects of oral nifedipine and intravenous dihydralazine in patients with severe pre-eclampsia.
    Visser W; Wallenburg HC
    J Hypertens; 1995 Jul; 13(7):791-5. PubMed ID: 7594443
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognosis for pre-eclampsia complicated by 5 g or more of proteinuria in 24 hours.
    Chua S; Redman CW
    Eur J Obstet Gynecol Reprod Biol; 1992 Jan; 43(1):9-12. PubMed ID: 1737613
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Hypertension in pregnancy].
    Sumino H; Ichikawa S
    Nihon Rinsho; 2004 Mar; 62 Suppl 3():431-4. PubMed ID: 15171412
    [No Abstract]   [Full Text] [Related]  

  • 40. Ketanserin versus dihydralazine in the management of severe early-onset preeclampsia: maternal outcome.
    Bolte AC; van Eyck J; Kanhai HH; Bruinse HW; van Geijn HP; Dekker GA
    Am J Obstet Gynecol; 1999 Feb; 180(2 Pt 1):371-7. PubMed ID: 9988803
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.